CG-RAD-28 Transrectal Ultrasonography

This policy addresses transrectal ultrasonography (TRUS) of the prostate. TRUS is covered when used to guide a prostate biopsy in patients with suspected prostate cancer based on an abnormal digital rectal exam (DRE), PSA > 3.0 ng/mL, or other concerning medical history. It is not covered when these criteria are not met and for all other indications, including use as a primary screening test for prostate cancer.

"Transrectal ultrasonography (TRUS) is consideredmedically necessaryforanyof the following indications:"

Sign up to see full coverage criteria, indications, and limitations.